Despite the heterogeneity of these cancers, we previously reported that the overexpression of two proteins, IGF2BP1 and cIAP1, occurs in all RMS patient-derived cell lines tested and in 75% of primary tumours [13]. The gene discussed is BIRC2; the disease is cancer.